Biodesix (BDSX) Stock: Buy, Sell, or Hold?
BDSX - Biodesix, Inc. Common Stock
$26.97
0.93 (3.55%)
â˛
5d:
+1.85%
30d:
+11.33%
90d:
+82.2%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 02, 2026
Get Alerted When BDSX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: BDSX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: BDSX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: BDSX is currently trading at $26.96, which is considered slightly high relative to its 30-day fair value range of $23.23 to $27.35.
Technical Outlook: Technically, BDSX is in a strong uptrend. Immediate support is located at $24.07, while resistance sits at $28.62. The stock is showing strong short-term momentum, up 3.6% recently.
Market Sentiment: BDSX scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $34.00 (+30.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BDSX is in a strong uptrend. Immediate support is located at $24.07, while resistance sits at $28.62. The stock is showing strong short-term momentum, up 3.6% recently.
Market Sentiment: BDSX scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $34.00 (+30.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$23.23 -
$27.35
Company Quality Score
38/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
47.4%
All Signals
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.6%)
- BULLISH: Trading 30.6% below Wall St target ($34.00)
- WARNING: Composite score 38/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$23.23 -
$27.35
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$24.07
Resistance Level
$28.62
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-15.61
Wall Street Target
$34.00
(+30.6%)
Revenue Growth (YoY)
34.2%
Profit Margin
-27.0%
Share & Embed Analysis
Last updated: September 11, 2026 4:49 PM ET
Data refreshes hourly during market hours. Next update: 5:49 PM
Data refreshes hourly during market hours. Next update: 5:49 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BDSX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher ScientificâĻ |
STRONG BUY
31 analysts |
$638 | 51 HOLD |
|
EXAS
EXACT Sciences CorporatiâĻ |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$229 | 49 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$194 | 49 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$338 | 47 HOLD |
